[5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide

C119H103FN18O16 — CID 158262637

About [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide

[5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide (PubChem CID 158262637) has the molecular formula C119H103FN18O16 and a molecular weight of 2060.24 g/mol. Its IUPAC name is [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide.

Molecular Properties

• Compound Name: [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide
• PubChem CID: 158262637
• Molecular Formula: C119H103FN18O16
• Molecular Weight: 2060.24 g/mol
• Exact Mass: 2058.78
• IUPAC Name: [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide
• SMILES: CC1(C(=O)Nc2ccccc2)CN(C(=O)c2cc(-c3ccccc3)on2)C1.COc1ccc(-c2cc(C(=O)N3CC(c4cccc(F)c4)C3)no2)cc1OC.Cn1cc2ccc(-c3cc(C(=O)N4CC(c5ccccc5)C4)no3)cc2n1.O=C(Nc1ccccc1)C1CN(C(=O)c2cc(-c3ccccc3)on2)C1.O=C(c1cc(-c2ccccn2)on1)N1CC(c2ccccc2)C1.O=C(c1cc(-c2cccnc2)on1)N1CC(c2ccccc2)C1
• InChI: InChI=1S/C21H19FN2O4.C21H18N4O2.C21H19N3O3.C20H17N3O3.2C18H15N3O2/c1-26-18-7-6-14(9-20(18)27-2)19-10-17(23-28-19)21(25)24-11-15(12-24)13-4-3-5-16(22)8-13;1-24-11-16-8-7-15(9-18(16)22-24)20-10-19(23-27-20)21(26)25-12-17(13-25)14-5-3-2-4-6-14;1-21(20(26)22-16-10-6-3-7-11-16)13-24(14-21)19(25)17-12-18(27-23-17)15-8-4-2-5-9-15;24-19(21-16-9-5-2-6-10-16)15-12-23(13-15)20(25)17-11-18(26-22-17)14-7-3-1-4-8-14;22-18(21-11-14(12-21)13-6-2-1-3-7-13)16-10-17(23-20-16)15-8-4-5-9-19-15;22-18(21-11-15(12-21)13-5-2-1-3-6-13)16-9-17(23-20-16)14-7-4-8-19-10-14/h3-10,15H,11-12H2,1-2H3;2-11,17H,12-13H2,1H3;2-12H,13-14H2,1H3,(H,22,26);1-11,15H,12-13H2,(H,21,24);1-10,14H,11-12H2;1-10,15H,11-12H2
• InChIKey: GIBCDHBZKVILQT-UHFFFAOYSA-N
• XLogP: 19.65
• TPSA: 398.30 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 26
• Rotatable Bonds: 22
• Heavy Atoms: 154
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2060.24
LogP ≤ 5	19.65
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	26

Frequently Asked Questions

What is the IUPAC name of [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide?

The IUPAC name of [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide (CID 158262637) is [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide.

What is the SMILES notation for [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide?

The canonical SMILES for [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide is CC1(C(=O)Nc2ccccc2)CN(C(=O)c2cc(-c3ccccc3)on2)C1.COc1ccc(-c2cc(C(=O)N3CC(c4cccc(F)c4)C3)no2)cc1OC.Cn1cc2ccc(-c3cc(C(=O)N4CC(c5ccccc5)C4)no3)cc2n1.O=C(Nc1ccccc1)C1CN(C(=O)c2cc(-c3ccccc3)on2)C1.O=C(c1cc(-c2ccccn2)on1)N1CC(c2ccccc2)C1.O=C(c1cc(-c2cccnc2)on1)N1CC(c2ccccc2)C1.

What is the InChIKey of [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide?

The InChIKey is GIBCDHBZKVILQT-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H19FN2O4.C21H18N4O2.C21H19N3O3.C20H17N3O3.2C18H15N3O2/c1-26-18-7-6-14(9-20(18)27-2)19-10-17(23-28-19)21(25)24-11-15(12-24)13-4-3-5-16(22)8-13;1-24-11-16-8-7-15(9-18(16)22-24)20-10-19(23-27-20)21(26)25-12-17(13-25)14-5-3-2-4-6-14;1-21(20(26)22-16-10-6-3-7-11-16)13-24(14-21)19(25)17-12-18(27-23-17)15-8-4-2-5-9-15;24-19(21-16-9-5-2-6-10-16)15-12-23(13-15)20(25)17-11-18(26-22-17)14-7-3-1-4-8-14;22-18(21-11-14(12-21)13-6-2-1-3-7-13)16-10-17(23-20-16)15-8-4-5-9-19-15;22-18(21-11-15(12-21)13-5-2-1-3-6-13)16-9-17(23-20-16)14-7-4-8-19-10-14/h3-10,15H,11-12H2,1-2H3;2-11,17H,12-13H2,1H3;2-12H,13-14H2,1H3,(H,22,26);1-11,15H,12-13H2,(H,21,24);1-10,14H,11-12H2;1-10,15H,11-12H2.

What are the key properties of [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide?

[5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide has a molecular weight of 2060.24 g/mol, XLogP of 19.65, 22 rotatable bonds, 2 hydrogen bond donors, and 26 hydrogen bond acceptors.

Where does this data come from?

All data for [5-(3,4-dimethoxyphenyl)-1,2-oxazol-3-yl]-[3-(3-fluorophenyl)azetidin-1-yl]methanone;[5-(2-methylindazol-6-yl)-1,2-oxazol-3-yl]-(3-phenylazetidin-1-yl)methanone;3-methyl-N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide;(3-phenylazetidin-1-yl)-(5-pyridin-2-yl-1,2-oxazol-3-yl)methanone;(3-phenylazetidin-1-yl)-(5-pyridin-3-yl-1,2-oxazol-3-yl)methanone;N-phenyl-1-(5-phenyl-1,2-oxazole-3-carbonyl)azetidine-3-carboxamide is sourced from PubChem (CID 158262637), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).